After Triumphing Over Trian, DuPont Sets Board Of Directors For Chemours Spinoff
DuPont (DD) unveiled the future board of directors at its performance chemicals spinoff, Chemour, earlier this week and poor Nelson Peltz didn’t make the cut here either. Surprisingly, the media isn’t covering this board situation in the same manner as last week’s ‘historic’ proxy battle, which witnessed DuPont CEO Ellen Kullman take down Nelson Peltz’s Trian Fund at the ballot box. The… Read More »